Stock Scorer
Stock Board CompareNew Screen
Donate
…
Report Measures Companies Earnings calendar Insider buying Fund portfolios
Sign in

Bristol-Myers Squibb Company (BMY) · Insider trading

What Bristol-Myers Squibb's directors, officers and largest holders bought and sold themselves, from the Form 4 each of them files with the SEC within two business days of a trade. Open-market purchases and sales first: those are the trades somebody chose to make at the market price.

Bought, 12 months
$0
0 insiders, 0 trades
Sold, 12 months
$2.29M
3 insiders, 0% under a plan
Net, 12 months
−$2.29M
bought less sold
Latest filing
2026-10-05
filings read to 2026-10-19

Bought and sold at the market, by month

Two years. Purchases above the line, sales below, in dollars.

2024-11: $100,064 bought 2024-11: $38,934 sold 2025-01 2025-02: $210,100 bought 2025-04: $202,215 bought 2025-05: $3,702 sold 2025-07 2025-08: $16,719 sold 2025-09: $2.65M sold 2026-01 2026-04: $1.85M sold 2026-07 2026-08: $33,750 sold 2026-09: $403,498 sold
Bought Sold Largest month: $2.65M

Who traded, two years

InsiderBoughtSold TradesLast tradeHolds after
Elkins David VEVP, Chief Financial Officer – $4.50M 3 2026-04-01 163,729
Massacesi CristianEVP,Chief Med Offr,Head of Dev – $403,498 1 2026-09-09 18,748
Hirawat SamitEVP,Chief Med.Offr.,Drug Dev. $402,280 – 3 2025-04-25 83,513
Boerner Christopher S.Director, Chief Executive Officer $110,100 – 1 2025-02-20 104,626
Holzer Phil MSVP and Controller – $72,684 2 2026-08-25 16,862
Short Bartie WendyEVP, Corporate Affairs – $16,719 1 2025-08-02 5,066
Hickey BenjaminPresident, RayzeBio Org. – $3,702 1 2025-05-09 –

Open-market purchases and sales

Newest first. “Plan” marks a trade made under a 10b5-1 plan set up in advance.

DateInsiderTradeShares PriceValueHolds afterFiling
2026-09-09 Massacesi CristianEVP,Chief Med Offr,Head of Dev Sale 6,249 64.57 $403,498 18,748 Form 4
2026-08-25 Holzer Phil MSVP and Controller Sale 500 67.50 $33,750 16,862 Form 4
2026-04-01 Elkins David VEVP, Chief Financial Officer Sale 25,519 61.60 $1.57M 163,729 Form 4
2026-04-01 Elkins David VEVP, Chief Financial Officer Sale 4,481 62.05 $278,046 159,248 Form 4
2025-09-02 Elkins David VEVP, Chief Financial Officer Sale 56,000 47.33 $2.65M 167,379 Form 4
2025-08-02 Short Bartie WendyEVP, Corporate Affairs Sale 378 44.23 $16,719 5,066 Form 4
2025-05-09 Hickey BenjaminPresident, RayzeBio Org. Saleindirect 97 38.01 $3,702 0 Form 4
2025-04-25 Hirawat SamitEVP,Chief Med.Offr.,Drug Dev. Buy 4,250 47.58 $202,215 83,513 Form 4
2025-02-20 Boerner Christopher S.Director, Chief Executive Officer Buy 2,000 55.05 $110,100 104,626 Form 4
2025-02-14 Hirawat SamitEVP,Chief Med.Offr.,Drug Dev. Buy 1,823 54.84 $100,000 63,932 Form 4
2024-11-04 Holzer Phil MSVP and Controller Sale 700 55.62 $38,934 11,760 Form 4
2024-11-01 Hirawat SamitEVP,Chief Med.Offr.,Drug Dev. Buy 1,830 54.68 $100,064 62,109 Form 4

Grants, exercises and other transactions

Pay, tax and paperwork rather than a choice to trade at the market price. Two years.

105 × option exercise103 × shares withheld for tax84 × other4 × gift
Show them
DateInsiderWhatShares PriceHolds afterFiling
2026-10-02 Gallman CariEVP, General Counsel Option exercise M +4,559 – 18,208 Form 4
2026-10-02 Gallman CariEVP, General Counsel Shares withheld for tax F −2,332 61.15 15,876 Form 4
2026-09-01 Short Bartie WendyEVP, Corporate Affairs Option exercise M +1,236 66.92 13,317 Form 4
2026-09-01 Short Bartie WendyEVP, Corporate Affairs Shares withheld for tax F −633 66.92 12,684 Form 4
2026-08-01 Gallman CariEVP, General Counsel Option exercise M +1,061 – 14,192 Form 4
2026-08-01 Gallman CariEVP, General Counsel Shares withheld for tax F −543 65.31 13,649 Form 4
2026-08-01 Massacesi CristianEVP,Chief Med Offr,Head of Dev Option exercise M +51,172 – 51,172 Form 4
2026-08-01 Massacesi CristianEVP,Chief Med Offr,Head of Dev Shares withheld for tax F −26,175 65.31 24,997 Form 4
2026-06-15 Haller Julia ADirector Option exercise M +20,460 53.76 34,079 Form 4
2026-06-03 Short Bartie WendyEVP, Corporate Affairs Option exercise M +8,040 – 15,957 Form 4
2026-06-03 Short Bartie WendyEVP, Corporate Affairs Shares withheld for tax F −3,876 54.72 12,081 Form 4
2026-05-01 Lenkowsky AdamEVP, Chief Commercial Officer Option exercise M +1,373 – 20,508 Form 4
2026-05-01 Lenkowsky AdamEVP, Chief Commercial Officer Other J −203 – 20,305 Form 4
2026-05-01 Lenkowsky AdamEVP, Chief Commercial Officer Shares withheld for tax F −599 58.22 19,706 Form 4
2026-04-01 Shanahan KarinEVP, Chief Supply Chain & Ops Option exercise M +3,307 – 27,580 Form 4
2026-04-01 Shanahan KarinEVP, Chief Supply Chain & Ops Shares withheld for tax F −1,692 61.73 25,888 Form 4
2026-03-10 Elkins David VEVP, Chief Financial Officer Option exercise M +7,654 – 175,033 Form 4
2026-03-10 Elkins David VEVP, Chief Financial Officer Other J −860 – 174,173 Form 4
2026-03-10 Elkins David VEVP, Chief Financial Officer Shares withheld for tax F −2,883 60.13 171,290 Form 4
2026-03-10 Elkins David VEVP, Chief Financial Officer Option exercise M +7,904 – 179,194 Form 4
2026-03-10 Elkins David VEVP, Chief Financial Officer Other J −854 – 178,340 Form 4
2026-03-10 Elkins David VEVP, Chief Financial Officer Shares withheld for tax F −2,991 60.13 175,349 Form 4
2026-03-10 Elkins David VEVP, Chief Financial Officer Option exercise M +47,424 – 222,773 Form 4
2026-03-10 Elkins David VEVP, Chief Financial Officer Other J −23,285 – 199,488 Form 4
2026-03-10 Elkins David VEVP, Chief Financial Officer Shares withheld for tax F −10,240 60.13 189,248 Form 4
2026-03-10 Boerner Christopher S.Director, Chief Executive Officer Option exercise M +6,618 – 7,800 Form 4
2026-03-10 Boerner Christopher S.Director, Chief Executive Officer Other J −743 – 7,057 Form 4
2026-03-10 Boerner Christopher S.Director, Chief Executive Officer Shares withheld for tax F −3,006 60.13 4,051 Form 4
2026-03-10 Boerner Christopher S.Director, Chief Executive Officer Option exercise M +6,733 – 10,784 Form 4
2026-03-10 Boerner Christopher S.Director, Chief Executive Officer Other J −727 – 10,057 Form 4
2026-03-10 Boerner Christopher S.Director, Chief Executive Officer Shares withheld for tax F −3,073 60.13 6,984 Form 4
2026-03-10 Boerner Christopher S.Director, Chief Executive Officer Option exercise M +40,398 – 47,382 Form 4
2026-03-10 Boerner Christopher S.Director, Chief Executive Officer Other J −19,835 – 27,547 Form 4
2026-03-10 Boerner Christopher S.Director, Chief Executive Officer Shares withheld for tax F −10,518 60.13 17,029 Form 4
2026-03-10 Boerner Christopher S.Director, Chief Executive Officer Option exercise M +17,788 – 34,817 Form 4
2026-03-10 Boerner Christopher S.Director, Chief Executive Officer Other J −8,734 – 26,083 Form 4
2026-03-10 Boerner Christopher S.Director, Chief Executive Officer Shares withheld for tax F −4,632 60.13 21,451 Form 4
2026-03-10 Plenge Robert MEVP, Chief Research Officer Option exercise M +1,107 – 16,946 Form 4
2026-03-10 Plenge Robert MEVP, Chief Research Officer Other J −124 – 16,822 Form 4
2026-03-10 Plenge Robert MEVP, Chief Research Officer Shares withheld for tax F −436 60.13 16,386 Form 4
2026-03-10 Plenge Robert MEVP, Chief Research Officer Option exercise M +2,342 – 18,728 Form 4
2026-03-10 Plenge Robert MEVP, Chief Research Officer Other J −253 – 18,475 Form 4
2026-03-10 Plenge Robert MEVP, Chief Research Officer Shares withheld for tax F −927 60.13 17,548 Form 4
2026-03-10 Plenge Robert MEVP, Chief Research Officer Option exercise M +14,052 – 31,600 Form 4
2026-03-10 Plenge Robert MEVP, Chief Research Officer Other J −6,900 – 24,700 Form 4
2026-03-10 Plenge Robert MEVP, Chief Research Officer Shares withheld for tax F −3,172 60.13 21,528 Form 4
2026-03-10 Meyers Gregory ScottEVP, Chief Digital & Tech Off. Option exercise M +2,839 – 24,267 Form 4
2026-03-10 Meyers Gregory ScottEVP, Chief Digital & Tech Off. Other J −319 – 23,948 Form 4
2026-03-10 Meyers Gregory ScottEVP, Chief Digital & Tech Off. Shares withheld for tax F −1,069 60.13 22,879 Form 4
2026-03-10 Meyers Gregory ScottEVP, Chief Digital & Tech Off. Option exercise M +3,293 – 26,172 Form 4
2026-03-10 Meyers Gregory ScottEVP, Chief Digital & Tech Off. Other J −356 – 25,816 Form 4
2026-03-10 Meyers Gregory ScottEVP, Chief Digital & Tech Off. Shares withheld for tax F −1,246 60.13 24,570 Form 4
2026-03-10 Meyers Gregory ScottEVP, Chief Digital & Tech Off. Option exercise M +19,760 – 44,330 Form 4
2026-03-10 Meyers Gregory ScottEVP, Chief Digital & Tech Off. Other J −9,702 – 34,628 Form 4
2026-03-10 Meyers Gregory ScottEVP, Chief Digital & Tech Off. Shares withheld for tax F −4,267 60.13 30,361 Form 4
2026-03-10 Shanahan KarinEVP, Chief Supply Chain & Ops Option exercise M +2,448 – 19,313 Form 4
2026-03-10 Shanahan KarinEVP, Chief Supply Chain & Ops Other J −275 – 19,038 Form 4
2026-03-10 Shanahan KarinEVP, Chief Supply Chain & Ops Shares withheld for tax F −1,112 60.13 17,926 Form 4
2026-03-10 Shanahan KarinEVP, Chief Supply Chain & Ops Option exercise M +3,293 – 21,219 Form 4
2026-03-10 Shanahan KarinEVP, Chief Supply Chain & Ops Other J −356 – 20,863 Form 4
2026-03-10 Shanahan KarinEVP, Chief Supply Chain & Ops Shares withheld for tax F −1,503 60.13 19,360 Form 4
2026-03-10 Shanahan KarinEVP, Chief Supply Chain & Ops Option exercise M +19,760 – 39,120 Form 4
2026-03-10 Shanahan KarinEVP, Chief Supply Chain & Ops Other J −9,702 – 29,418 Form 4
2026-03-10 Shanahan KarinEVP, Chief Supply Chain & Ops Shares withheld for tax F −5,145 60.13 24,273 Form 4
2026-03-10 Lenkowsky AdamEVP, Chief Commercial Officer Option exercise M +1,828 – 14,267 Form 4
2026-03-10 Lenkowsky AdamEVP, Chief Commercial Officer Other J −205 – 14,062 Form 4
2026-03-10 Lenkowsky AdamEVP, Chief Commercial Officer Shares withheld for tax F −831 60.13 13,231 Form 4
2026-03-10 Lenkowsky AdamEVP, Chief Commercial Officer Option exercise M +2,000 – 15,231 Form 4
2026-03-10 Lenkowsky AdamEVP, Chief Commercial Officer Other J −216 – 15,015 Form 4
2026-03-10 Lenkowsky AdamEVP, Chief Commercial Officer Shares withheld for tax F −913 60.13 14,102 Form 4
2026-03-10 Lenkowsky AdamEVP, Chief Commercial Officer Option exercise M +12,002 – 26,104 Form 4
2026-03-10 Lenkowsky AdamEVP, Chief Commercial Officer Other J −5,893 – 20,211 Form 4
2026-03-10 Lenkowsky AdamEVP, Chief Commercial Officer Shares withheld for tax F −3,125 60.13 17,086 Form 4
2026-03-10 Lenkowsky AdamEVP, Chief Commercial Officer Option exercise M +8,241 – 25,327 Form 4
2026-03-10 Lenkowsky AdamEVP, Chief Commercial Officer Other J −4,046 – 21,281 Form 4
2026-03-10 Lenkowsky AdamEVP, Chief Commercial Officer Shares withheld for tax F −2,146 60.13 19,135 Form 4
2026-03-10 Gallman CariEVP, General Counsel Option exercise M +912 – 11,978 Form 4
2026-03-10 Gallman CariEVP, General Counsel Other J −102 – 11,876 Form 4
2026-03-10 Gallman CariEVP, General Counsel Shares withheld for tax F −415 60.13 11,461 Form 4
2026-03-10 Gallman CariEVP, General Counsel Option exercise M +867 – 12,328 Form 4
2026-03-10 Gallman CariEVP, General Counsel Other J −94 – 12,234 Form 4
2026-03-10 Gallman CariEVP, General Counsel Shares withheld for tax F −396 60.13 11,838 Form 4
2026-03-10 Gallman CariEVP, General Counsel Option exercise M +5,201 – 17,039 Form 4
2026-03-10 Gallman CariEVP, General Counsel Other J −2,554 – 14,485 Form 4
2026-03-10 Gallman CariEVP, General Counsel Shares withheld for tax F −1,354 60.13 13,131 Form 4
2026-03-10 Poole Ahn AmandaEVP, Chief People Officer Option exercise M +811 – 6,007 Form 4
2026-03-10 Poole Ahn AmandaEVP, Chief People Officer Other J −91 – 5,916 Form 4
2026-03-10 Poole Ahn AmandaEVP, Chief People Officer Shares withheld for tax F −369 60.13 5,547 Form 4
2026-03-10 Poole Ahn AmandaEVP, Chief People Officer Option exercise M +803 – 6,350 Form 4
2026-03-10 Poole Ahn AmandaEVP, Chief People Officer Other J −87 – 6,263 Form 4
2026-03-10 Poole Ahn AmandaEVP, Chief People Officer Shares withheld for tax F −367 60.13 5,896 Form 4
2026-03-10 Poole Ahn AmandaEVP, Chief People Officer Option exercise M +4,822 – 10,718 Form 4
2026-03-10 Poole Ahn AmandaEVP, Chief People Officer Other J −2,368 – 8,350 Form 4
2026-03-10 Poole Ahn AmandaEVP, Chief People Officer Shares withheld for tax F −1,256 60.13 7,094 Form 4
2026-03-10 Hoch LynellePresident, Cell Therapy Org. Option exercise M +838 – 5,549 Form 4
2026-03-10 Hoch LynellePresident, Cell Therapy Org. Other J −94 – 5,455 Form 4
2026-03-10 Hoch LynellePresident, Cell Therapy Org. Shares withheld for tax F −212 60.13 5,243 Form 4
2026-03-10 Hoch LynellePresident, Cell Therapy Org. Option exercise M +1,050 – 6,293 Form 4
2026-03-10 Hoch LynellePresident, Cell Therapy Org. Other J −113 – 6,180 Form 4
2026-03-10 Hoch LynellePresident, Cell Therapy Org. Shares withheld for tax F −267 60.13 5,913 Form 4
2026-03-10 Hoch LynellePresident, Cell Therapy Org. Option exercise M +6,304 – 12,217 Form 4
2026-03-10 Hoch LynellePresident, Cell Therapy Org. Other J −3,095 – 9,122 Form 4
2026-03-10 Hoch LynellePresident, Cell Therapy Org. Shares withheld for tax F −912 60.13 8,210 Form 4
2026-03-10 Holzer Phil MSVP and Controller Option exercise M +811 – 15,778 Form 4
2026-03-10 Holzer Phil MSVP and Controller Other J −91 – 15,687 Form 4
2026-03-10 Holzer Phil MSVP and Controller Shares withheld for tax F −261 60.13 15,426 Form 4
2026-03-10 Holzer Phil MSVP and Controller Option exercise M +768 – 16,194 Form 4
2026-03-10 Holzer Phil MSVP and Controller Other J −83 – 16,111 Form 4
2026-03-10 Holzer Phil MSVP and Controller Shares withheld for tax F −248 60.13 15,863 Form 4
2026-03-10 Holzer Phil MSVP and Controller Option exercise M +4,612 – 20,475 Form 4
2026-03-10 Holzer Phil MSVP and Controller Other J −2,264 – 18,211 Form 4
2026-03-10 Holzer Phil MSVP and Controller Shares withheld for tax F −849 60.13 17,362 Form 4
2026-03-10 Short Bartie WendyEVP, Corporate Affairs Option exercise M +639 – 6,308 Form 4
2026-03-10 Short Bartie WendyEVP, Corporate Affairs Other J −72 – 6,236 Form 4
2026-03-10 Short Bartie WendyEVP, Corporate Affairs Shares withheld for tax F −205 60.13 6,031 Form 4
2026-03-10 Short Bartie WendyEVP, Corporate Affairs Option exercise M +749 – 6,780 Form 4
2026-03-10 Short Bartie WendyEVP, Corporate Affairs Other J −81 – 6,699 Form 4
2026-03-10 Short Bartie WendyEVP, Corporate Affairs Shares withheld for tax F −242 60.13 6,457 Form 4
2026-03-10 Short Bartie WendyEVP, Corporate Affairs Option exercise M +4,495 – 10,952 Form 4
2026-03-10 Short Bartie WendyEVP, Corporate Affairs Other J −2,207 – 8,745 Form 4
2026-03-10 Short Bartie WendyEVP, Corporate Affairs Shares withheld for tax F −828 60.13 7,917 Form 4
2026-02-27 Hickey BenjaminPresident, RayzeBio Org. Option exercise M +3,286 – 18,344 Form 4
2026-02-27 Hickey BenjaminPresident, RayzeBio Org. Shares withheld for tax F −1,672 62.37 16,672 Form 4
2026-02-01 Hickey BenjaminPresident, RayzeBio Org. Option exercise M +10,079 – 18,868 Form 4
2026-02-01 Hickey BenjaminPresident, RayzeBio Org. Shares withheld for tax F −3,810 55.05 15,058 Form 4
2026-02-01 Meyers Gregory ScottEVP, Chief Digital & Tech Off. Option exercise M +2,543 – 22,261 Form 4
2026-02-01 Meyers Gregory ScottEVP, Chief Digital & Tech Off. Shares withheld for tax F −833 55.05 21,428 Form 4
2025-11-01 Boerner Christopher S.Director, Chief Executive Officer Option exercise M +2,964 – 2,964 Form 4
2025-11-01 Boerner Christopher S.Director, Chief Executive Officer Other J −544 – 2,420 Form 4
2025-11-01 Boerner Christopher S.Director, Chief Executive Officer Shares withheld for tax F −1,238 46.07 1,182 Form 4
2025-11-01 Meyers Gregory ScottEVP, Chief Digital & Tech Off. Option exercise M +6,281 – 22,383 Form 4
2025-11-01 Meyers Gregory ScottEVP, Chief Digital & Tech Off. Shares withheld for tax F −2,665 46.07 19,718 Form 4
2025-11-01 Shanahan KarinEVP, Chief Supply Chain & Ops Option exercise M +6,281 – 20,078 Form 4
2025-11-01 Shanahan KarinEVP, Chief Supply Chain & Ops Shares withheld for tax F −3,213 46.07 16,865 Form 4
2025-10-02 Gallman CariEVP, General Counsel Option exercise M +4,558 – 13,398 Form 4
2025-10-02 Gallman CariEVP, General Counsel Shares withheld for tax F −2,332 45.73 11,066 Form 4
2025-09-01 Short Bartie WendyEVP, Corporate Affairs Option exercise M +1,235 – 6,301 Form 4
2025-09-01 Short Bartie WendyEVP, Corporate Affairs Shares withheld for tax F −632 47.18 5,669 Form 4
2025-08-02 Short Bartie WendyEVP, Corporate Affairs Option exercise M +738 – 5,444 Form 4
2025-08-01 Gallman CariEVP, General Counsel Option exercise M +1,061 – 9,383 Form 4
2025-08-01 Gallman CariEVP, General Counsel Shares withheld for tax F −543 44.23 8,840 Form 4
2025-06-13 Boerner Christopher S.Director, Chief Executive Officer Gift G −62,719 – 0 Form 4
2025-06-13 Boerner Christopher S.Director, Chief Executive Officer Gift G +62,719 – 125,439 Form 4
2025-06-03 Boerner Christopher S.Director, Chief Executive Officer Gift G −62,720 – 62,719 Form 4
2025-06-03 Boerner Christopher S.Director, Chief Executive Officer Gift G +62,720 – 62,720 Form 4
2025-06-03 Short Bartie WendyEVP, Corporate Affairs Option exercise M +8,040 – 8,040 Form 4
2025-06-03 Short Bartie WendyEVP, Corporate Affairs Shares withheld for tax F −3,334 48.09 4,706 Form 4
2025-04-01 Shanahan KarinEVP, Glob. Prod. Dev. & Supply Option exercise M +3,306 – 15,489 Form 4
2025-04-01 Shanahan KarinEVP, Glob. Prod. Dev. & Supply Shares withheld for tax F −1,692 59.55 13,797 Form 4
2025-03-10 Boerner Christopher S.Director, Chief Executive Officer Option exercise M +6,985 – 111,611 Form 4
2025-03-10 Boerner Christopher S.Director, Chief Executive Officer Other J −482 – 111,129 Form 4
2025-03-10 Boerner Christopher S.Director, Chief Executive Officer Shares withheld for tax F −3,327 63.11 107,802 Form 4
2025-03-10 Boerner Christopher S.Director, Chief Executive Officer Option exercise M +6,616 – 114,418 Form 4
2025-03-10 Boerner Christopher S.Director, Chief Executive Officer Other J −1,154 – 113,264 Form 4
2025-03-10 Boerner Christopher S.Director, Chief Executive Officer Shares withheld for tax F −2,794 63.11 110,470 Form 4
2025-03-10 Boerner Christopher S.Director, Chief Executive Officer Option exercise M +6,733 – 117,203 Form 4
2025-03-10 Boerner Christopher S.Director, Chief Executive Officer Other J −1,147 – 116,056 Form 4
2025-03-10 Boerner Christopher S.Director, Chief Executive Officer Shares withheld for tax F −2,858 63.11 113,198 Form 4
2025-03-10 Boerner Christopher S.Director, Chief Executive Officer Option exercise M +39,700 – 152,898 Form 4
2025-03-10 Boerner Christopher S.Director, Chief Executive Officer Other J −14,641 – 138,257 Form 4
2025-03-10 Boerner Christopher S.Director, Chief Executive Officer Shares withheld for tax F −12,818 63.11 125,439 Form 4
2025-03-10 Elkins David VEVP, Chief Financial Officer Option exercise M +8,045 – 203,013 Form 4
2025-03-10 Elkins David VEVP, Chief Financial Officer Other J −555 – 202,458 Form 4
2025-03-10 Elkins David VEVP, Chief Financial Officer Shares withheld for tax F −3,178 63.11 199,280 Form 4
2025-03-10 Elkins David VEVP, Chief Financial Officer Option exercise M +7,652 – 206,932 Form 4
2025-03-10 Elkins David VEVP, Chief Financial Officer Other J −1,335 – 205,597 Form 4
2025-03-10 Elkins David VEVP, Chief Financial Officer Shares withheld for tax F −2,680 63.11 202,917 Form 4
2025-03-10 Elkins David VEVP, Chief Financial Officer Option exercise M +7,904 – 210,821 Form 4
2025-03-10 Elkins David VEVP, Chief Financial Officer Other J −1,347 – 209,474 Form 4
2025-03-10 Elkins David VEVP, Chief Financial Officer Shares withheld for tax F −2,782 63.11 206,692 Form 4
2025-03-10 Elkins David VEVP, Chief Financial Officer Option exercise M +45,916 – 252,608 Form 4
2025-03-10 Elkins David VEVP, Chief Financial Officer Other J −16,934 – 235,674 Form 4
2025-03-10 Elkins David VEVP, Chief Financial Officer Shares withheld for tax F −12,295 63.11 223,379 Form 4
2025-03-10 Gallman CariEVP, Corporate Affairs Option exercise M +349 – 5,368 Form 4
2025-03-10 Gallman CariEVP, Corporate Affairs Other J −24 – 5,344 Form 4
2025-03-10 Gallman CariEVP, Corporate Affairs Shares withheld for tax F −118 63.11 5,226 Form 4
2025-03-10 Gallman CariEVP, Corporate Affairs Option exercise M +910 – 6,136 Form 4
2025-03-10 Gallman CariEVP, Corporate Affairs Other J −159 – 5,977 Form 4
2025-03-10 Gallman CariEVP, Corporate Affairs Shares withheld for tax F −272 63.11 5,705 Form 4
2025-03-10 Gallman CariEVP, Corporate Affairs Option exercise M +867 – 6,572 Form 4
2025-03-10 Gallman CariEVP, Corporate Affairs Other J −148 – 6,424 Form 4
2025-03-10 Gallman CariEVP, Corporate Affairs Shares withheld for tax F −260 63.11 6,164 Form 4
2025-03-10 Gallman CariEVP, Corporate Affairs Option exercise M +5,462 – 11,626 Form 4
2025-03-10 Gallman CariEVP, Corporate Affairs Other J −2,014 – 9,612 Form 4
2025-03-10 Gallman CariEVP, Corporate Affairs Shares withheld for tax F −1,290 63.11 8,322 Form 4
2025-03-10 Hirawat SamitEVP,Chief Med.Offr.,Drug Dev. Option exercise M +4,886 – 68,818 Form 4
2025-03-10 Hirawat SamitEVP,Chief Med.Offr.,Drug Dev. Other J −337 – 68,481 Form 4
2025-03-10 Hirawat SamitEVP,Chief Med.Offr.,Drug Dev. Shares withheld for tax F −2,327 63.11 66,154 Form 4
2025-03-10 Hirawat SamitEVP,Chief Med.Offr.,Drug Dev. Option exercise M +4,765 – 70,919 Form 4
2025-03-10 Hirawat SamitEVP,Chief Med.Offr.,Drug Dev. Other J −831 – 70,088 Form 4
2025-03-10 Hirawat SamitEVP,Chief Med.Offr.,Drug Dev. Shares withheld for tax F −2,013 63.11 68,075 Form 4
2025-03-10 Hirawat SamitEVP,Chief Med.Offr.,Drug Dev. Option exercise M +5,854 – 73,929 Form 4
2025-03-10 Hirawat SamitEVP,Chief Med.Offr.,Drug Dev. Other J −998 – 72,931 Form 4
2025-03-10 Hirawat SamitEVP,Chief Med.Offr.,Drug Dev. Shares withheld for tax F −2,484 63.11 70,447 Form 4
2025-03-10 Hirawat SamitEVP,Chief Med.Offr.,Drug Dev. Option exercise M +28,593 – 99,040 Form 4
2025-03-10 Hirawat SamitEVP,Chief Med.Offr.,Drug Dev. Other J −10,545 – 88,495 Form 4
2025-03-10 Hirawat SamitEVP,Chief Med.Offr.,Drug Dev. Shares withheld for tax F −9,232 63.11 79,263 Form 4
2025-03-10 Holzer Phil MSVP and Controller Option exercise M +701 – 12,461 Form 4
2025-03-10 Holzer Phil MSVP and Controller Other J −48 – 12,413 Form 4
2025-03-10 Holzer Phil MSVP and Controller Shares withheld for tax F −237 63.11 12,176 Form 4

How to read it

Buy, sale
Code P and S on the form: shares bought or sold in the market, at the market price. The other codes are mostly pay (a grant, an option exercised) or tax (shares the company withheld), and say little about what the insider thinks of the price.
Plan
A sale or purchase under a Rule 10b5-1 plan, set up in advance and running on its own schedule. Since April 2023 the form has a box for it. Much executive selling is planned and says more about diversifying than about the company.
Holds after
The shares the insider still held after the trade, in the form the trade was in (directly, or indirectly through a trust or a fund).
Value
Shares times the price the form reports, which is often an average over several fills on the day.

Read from the SEC's own quarterly data sets of Forms 3, 4 and 5, and from each day's filings since the last one. A correcting amendment replaces the lines it restates. Every row links to its filing. None of this is advice: insiders sell for many reasons, and buy for fewer.

Bristol-Myers Squibb's scores and multiples ›